China's E-cigarette Export Data for Germany, December 2023

Industry Insight by 2FIRSTS Mincy
Jan.30.2024
China's E-cigarette Export Data for Germany, December 2023
China's e-cigarette exports to Germany in December 2023 reached approximately $55.35 million, with a 22.22% month-on-month increase but a 19.87% year-on-year decrease.

According to the latest trade data updated by the General Administration of Customs of the People's Republic of China, 2FIRSTS has compiled the e-cigarette export data from China to Germany in December 2023. Here are the specifics:

China's E-cigarette Export Data for Germany, December 2023
Image source: 2FIRSTS (Created by Mincy)

 

The export volume amounts to approximately 55.35 million US dollars, marking a month-on-month increase of 22.22% but a year-on-year decline of 19.87%.

China's E-cigarette Export Data for Germany, December 2023
Source of the image: 2FIRSTS (Mincy's chart)

 

The export volume reached approximately 865 tons, increasing by 10.39% compared to the previous period and by 10.76% compared to the same period last year.

China's E-cigarette Export Data for Germany, December 2023
Image source: 2FIRSTS (graphics by Mincy)

 

The average export unit price is $63.95 per kilogram, showing a 10.71% increase on a monthly basis, but a 27.66% decrease compared to the same period last year. Additionally, the average price for "e-cigarettes and similar personal electronic vaporizers" is $18.9 per unit.

China's E-cigarette Export Data for Germany, December 2023
Image source: 2FIRSTS (created by Mincy)

 

Among them, "e-cigarettes and similar personal electronic vapor devices" account for 42% of the export category, while "non-combustible products without tobacco or reconstituted tobacco, containing nicotine for non-smoke inhalation" account for 58%.

China's E-cigarette Export Data for Germany, December 2023
Source of the image: 2FIRSTS (created by Mincy)

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Reuters: Big Tobacco Emerges as Winner After FDA Regulatory Shift
Reuters: Big Tobacco Emerges as Winner After FDA Regulatory Shift
According to Reuters, major tobacco companies may emerge as key beneficiaries after the U.S. FDA loosened regulations on vaping and nicotine pouch products, a shift that has sparked debate over public health risks.
Industry Insight
May.26
Vuse Alto Adds New U.S. Price Tier as BAT Pushes Deeper Into Mass-Market Vaping
Vuse Alto Adds New U.S. Price Tier as BAT Pushes Deeper Into Mass-Market Vaping
British American Tobacco (BAT) subsidiary Vuse Alto has recently adjusted its price tiers in U.S. convenience store channels, leveraging low-cost device kits and pod promotions to reinforce its positioning in the mid-priced closed-system e-cigarette market.
Jun.17
 FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
The U.S. Food and Drug Administration (FDA) has initiated scientific review of renewal applications for 22nd Century Group’s VLN reduced-nicotine cigarettes under the Modified Risk Tobacco Product (MRTP) pathway, with current authorizations set to expire in December 2026.
News
May.13
KT&G Overseas Tobacco Revenue Jumps 24.6%, Attracting Global Capital
KT&G Overseas Tobacco Revenue Jumps 24.6%, Attracting Global Capital
South Korean tobacco company KT&G is drawing growing global investor attention after reporting record overseas tobacco sales, with international institutions including Capital Group and BlackRock increasing their stakes.
Business
May.19
 Zyn Emerges as MAGA Cultural Symbol Amid FDA Policy Shift
Zyn Emerges as MAGA Cultural Symbol Amid FDA Policy Shift
According to The Wall Street Journal, nicotine pouch brand Zyn has rapidly gained popularity across the Trump administration and conservative political circles, including among U.S. Health Secretary Robert F. Kennedy Jr.
Business
May.20
FDA Warns Retailers Over Unauthorized Nicotine Pouches Resembling Candy and Everyday Products
FDA Warns Retailers Over Unauthorized Nicotine Pouches Resembling Candy and Everyday Products
The FDA issued warning letters to eight retailers selling unauthorized nicotine pouches and dissolvable tobacco products resembling candy, breath strips and cough drops. The action highlights rising scrutiny of packaging, youth appeal and accidental ingestion risks, as the agency clarifies enforcement priorities for unauthorized ENDS and nicotine pouch products while maintaining PMTA as the legal market pathway.
Special Report
May.21